Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00258258
Recruitment Status : Terminated (Withdrawn due to low accrual)
First Posted : November 24, 2005
Last Update Posted : February 1, 2013
Sponsor:
Information provided by (Responsible Party):
Roswell Park Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : March 2009
Study Completion Date : No date given